Literature DB >> 17568478

Epidemiology of vertebral osteomyelitis (VO) in France: analysis of hospital-discharge data 2002-2003.

L Grammatico1, S Baron, E Rusch, B Lepage, N Surer, J C Desenclos, J M Besnier.   

Abstract

Vertebral osteomyelitis (VO) is a rare event. To estimate the incidence of VO in France for 2002-2003, national hospital-discharge data were used. Hospital stays were categorized as definite, probable or possible VO. Unique patient identification numbers allowed the investigators to link patients with multiple hospital stays and to analyse data for individual patients. A sample of medical records was reviewed to assess the specificity of the VO case definition. In 2002-2003, 1977 and 2036 hospital stays corresponding to 1422 and 1425 patients (median age 59 years, male:female ratio 1.5) were classified as definite (64%), probable (24%) and possible (12%) VO. The overall incidence of VO was 2.4/100,000. Incidence increased with age: 0.3/100,000 (70 years). The main infectious agents reported were Staphylococcus spp. (38%) and Mycobacterium tuberculosis (31%). The most frequent comorbidities were septicaemia (27%) and endocarditis (9%). Three percent of patients died. A review of 90 medical records confirmed the diagnosis of VO in 94% of cases. Using a hospital database and a specific case definition, nationwide surveillance of VO is possible.

Entities:  

Mesh:

Year:  2007        PMID: 17568478      PMCID: PMC2870846          DOI: 10.1017/S0950268807008850

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Vertebral osteomyelitis in Göteborg, Sweden: a retrospective study of patients during 1990-95.

Authors:  M Beronius; B Bergman; R Andersson
Journal:  Scand J Infect Dis       Date:  2001

Review 2.  Infectious and inflammatory processes of the spine.

Authors:  A S Smith; S I Blaser
Journal:  Radiol Clin North Am       Date:  1991-07       Impact factor: 2.303

3.  [Current aspects of spinal tuberculosis: apropos of 16 case reports].

Authors:  V Barrière; P Gepner; F Bricaire; O Blétry; E Caumes
Journal:  Ann Med Interne (Paris)       Date:  1999-09

Review 4.  Diagnosis of tuberculous vertebral osteomyelitis (TVO) in a developed country and literature review.

Authors:  D Wang
Journal:  Spinal Cord       Date:  2005-09       Impact factor: 2.772

5.  A case ascertainment study of septic discitis: clinical, microbiological and radiological features.

Authors:  N Hopkinson; J Stevenson; S Benjamin
Journal:  QJM       Date:  2001-09

6.  Spontaneous pyogenic vertebral osteomyelitis in nondrug users.

Authors:  Joan M Nolla; Javier Ariza; Carmen Gómez-Vaquero; Jordi Fiter; Joaquín Bermejo; Josep Valverde; Daniel Roig Escofet; Francesc Gudiol
Journal:  Semin Arthritis Rheum       Date:  2002-02       Impact factor: 5.532

Review 7.  Spinal infections.

Authors:  E Turgut Tali
Journal:  Eur J Radiol       Date:  2004-05       Impact factor: 3.528

8.  Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients.

Authors:  C Perronne; J Saba; Z Behloul; D Salmon-Céron; C Leport; J L Vildé; M F Kahn
Journal:  Clin Infect Dis       Date:  1994-10       Impact factor: 9.079

9.  Analysis of 61 cases of vertebral osteomyelitis.

Authors:  M J Patzakis; S Rao; J Wilkins; T M Moore; P J Harvey
Journal:  Clin Orthop Relat Res       Date:  1991-03       Impact factor: 4.176

Review 10.  Management of vertebral diskitis and osteomyelitis.

Authors:  I A Khan; A R Vaccaro; D A Zlotolow
Journal:  Orthopedics       Date:  1999-08       Impact factor: 1.390

View more
  76 in total

1.  Adolescent vertebral osteomyelitis mimicking a neoplasm.

Authors:  Charlie D Wilson; Joshua Lee; Ronak Desai; Russell A Ward
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-10-16

Review 2.  Global relevance of literature on trauma.

Authors:  Shahryar Noordin; James G Wright; Andrew W Howard
Journal:  Clin Orthop Relat Res       Date:  2008-08-07       Impact factor: 4.176

3.  [Vertebral osteomyelitis].

Authors:  N Jung; H Seifert; J Siewe; G Fätkenheuer
Journal:  Internist (Berl)       Date:  2013-08       Impact factor: 0.743

4.  Clinical and microbiological outcomes in haematogenous spondylodiscitis treated conservatively.

Authors:  Tiziana Ascione; Giovanni Balato; Sigismondo Luca Di Donato; Pasquale Pagliano; Francesco Granata; Gianluca Colella; Carlo Ruosi
Journal:  Eur Spine J       Date:  2017-03-17       Impact factor: 3.134

5.  Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009.

Authors:  Hilal Maradit Kremers; Macaulay E Nwojo; Jeanine E Ransom; Christina M Wood-Wentz; L Joseph Melton; Paul M Huddleston
Journal:  J Bone Joint Surg Am       Date:  2015-05-20       Impact factor: 5.284

Review 6.  Spinal infections in children: A review.

Authors:  Rahul Tyagi
Journal:  J Orthop       Date:  2016-06-24

7.  Surgical treatment for pyogenic vertebral osteomyelitis using iodine-supported spinal instruments: initial case series of 14 patients.

Authors:  S Demura; H Murakami; T Shirai; S Kato; K Yoshioka; T Ota; T Ishii; T Igarashi; H Tsuchiya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-21       Impact factor: 3.267

8.  Outcome-related co-factors in 105 cases of vertebral osteomyelitis in a tertiary care hospital.

Authors:  M Loibl; L Stoyanov; C Doenitz; A Brawanski; P Wiggermann; W Krutsch; M Nerlich; M Oszwald; C Neumann; B Salzberger; F Hanses
Journal:  Infection       Date:  2014-01-21       Impact factor: 3.553

9.  Susceptibility Pattern of Microorganisms Isolated by Percutaneous Needle Biopsy in Nonbacteremic Pyogenic Vertebral Osteomyelitis.

Authors:  Sophie Desoutter; Jean-Philippe Cottier; Idir Ghout; Bertrand Issartel; Aurélien Dinh; Arnaud Martin; Robert Carlier; Louis Bernard
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

Review 10.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.